Nurse Practitioner, Family · New York, NY
NPI
1598807125
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave, Memorial Sloan Kettering Cancer Center M4
New York, NY, 10065
Phone (212) 639-3849
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
255 services
Medicare patients, 2024
122
Average age 75
Drug cost, 2024
$4.8M
1,299 prescriptions
Company payments, 2025
$15.51
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Coleen P Ranaghan was code 99214 (office e&m - established), 228 times for 101 patients. In total Coleen P Ranaghan billed 255 services in 5 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 228 | 101 | $73.90 | $17K |
| 38222 Other Organ Systems | Office | 21 | 21 | $53.31 | $1,120 |
By year: 2022 $16K for 241 services; 2023 $18K for 259 services; 2024 $18K for 255 services.
Medicare prescription drug claims, 2024
In 2024, the drug Coleen P Ranaghan prescribed most often to Medicare patients was Acyclovir, with 146 prescriptions and refills. In total Coleen P Ranaghan wrote 1,299 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 146 | 228 | 55 | $2,275 |
| Hydroxyurea Generic | 81 | 168 | 32 | $2,369 |
| Levofloxacin Generic | 74 | 86 | 33 | $1,657 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 49 | 57 | 16 | $356 |
| Venclexta Venetoclax | 45 | 45 | 22 | $403K |
| Allopurinol Generic | 45 | 61 | 19 | $312 |
| Posaconazole Generic | 38 | 38 | 18 | $38K |
| Pantoprazole Sodium Generic | 37 | 52 | 12 | $437 |
| Imbruvica Ibrutinib | 36 | 36 | Under 11 | $500K |
| Imatinib Mesylate Generic | 34 | 40 | Under 11 | $40K |
| Calquence Acalabrutinib Maleate | 32 | 32 | Under 11 | $470K |
| Rosuvastatin Calcium Generic | 31 | 53 | Under 11 | $275 |
| Amlodipine Besylate Generic | 23 | 39 | Under 11 | $142 |
| Idhifa Enasidenib Mesylate | 22 | 22 | Under 11 | $691K |
| Famotidine Generic | 21 | 37 | Under 11 | $106 |
Brand drugs: - claims; generic drugs: 974 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Coleen P Ranaghan $15.51 ($15.51 in general payments such as food, travel and fees) from 1 company. The largest payer was Shorla Oncology Inc. with $15.51.
| Company | Payments | Amount |
|---|---|---|
| Shorla Oncology Inc. | 1 | $15.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.